The Patented Medicine Prices Review Board published its new guidelines on Friday. The guidelines, which will take effect on Jan. 1, 2021, aim to modernize Canada’s pricing framework for patented medicines. They explain the steps that will typically be taken by the PMPRB’s staff in assessing whether a patented medicine appears to be priced excessively in Canada. The […]
Three-quarters (76 per cent) of Canadian business leaders say the Canada Emergency Wage Subsidy is a good investment to help the economy rebound and get Canadians back to work, according to a new survey by KPMG in Canada. The same amount said they’ve relied on funds from the wage subsidy to keep employees on payroll and more […]
The U.S. Department of Labor is taking jabs at the inclusion of environmental, social and governance products in capital accumulation plans — and it could be to members’ detriment. In late June, the Department of Labor proposed new rules around ESG products in retirement accounts. “The proposal is designed, in part, to make clear that . […]
The CFA Institute is calling out the lack of clarity and standardization around environmental, social and governance investment products. In a consultation paper, the organization proposed its own set of standards, welcoming industry stakeholders to weigh in. As interest in ESG products continues to grow from both retail and institutional investors, confusion remains about the […]
Quebec is applying new pension relief measures and is also extending the credit on employer contributions to the health services fund. The pension relief measures, which the federal government announced in early July, will allow registered pension plans to borrow money and extend the deadline to retroactively credit pensionable service under a defined benefit plan. […]
For defined contribution plan members who were intending to retire in the first half of 2020, the market crash caused by the coronavirus may have upended those plans. Markets reached a trough in March, followed by some recovery, but with little clarity on what investments will do next, it’s a challenging time for plan members […]
In its submission to the Patented Medicine Prices Review Board’s draft guidelines, the Canadian Life and Health Insurance Association is suggesting that the board consider disbursing excess revenues from pharmaceutical companies to employers rather than just to the provincial and territorial public payers. Currently, any excess revenues — determined by voluntary compliance undertaking or orders […]
Prime Minister Justin Trudeau says the government plans to move out-of-work Canadians into the employment insurance system and provide parallel support for millions set to exhaust emergency pandemic aid who don’t have EI to fall back on. The $80-billion Canada Emergency Response Benefit is set to wind down over the coming weeks, with those who […]
The federal government is easing eligibility rules for the government’s emergency wage subsidy and changing the amounts businesses can receive. The government had been under pressure to make the subsidy more accessible, specifically by loosening the requirement of a 30 per cent drop in revenues, so more companies under that cut-off can qualify. Speaking in Toronto […]
The Federal Court has upheld reforms to the Patented Medicines Pricing Review Board that updated the board’s reference countries for drug pricing and required it to review three new economic factors when determining whether patented medicines are excessively priced. The court ruled against an argument by Innovative Medicines Canada and 16 pharmaceutical companies in their […]